AMGN in the 13F filings
Amgen Inc · CUSIP 031162100
- Quarter end
- 30 Jun 2024
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 26 Jul 2024
- Managers listing it
- 20
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q1 2024 and Q2 2024; 19 listed it in both
- Shares listed
- 25,734,274
- combined, among listed positions
- Reported value
- $8.0bn
- combined, at the quarter end
Among the 94 comparable managers: 11 buyers (opened or added shares) and 9 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing AMGN in Q2 2024
20 of 20 holders
Largest increases and reductions, by shares
Increases
- Janus Henderson Group Ltdexisting position · 4,604,785 shares now+2,223,652
- T. Rowe Price Associates Incexisting position · 4,521,614 shares now+1,384,123
- Two Sigma Investments LPexisting position · 542,148 shares now+429,765
- Two Sigma Advisers LPexisting position · 716,900 shares now+367,200
- Farallon Capital Management LLCnew position · 232,000 shares now+232,000
Reductions
- Capital Research Global Investorsexisting position · 4,004,462 shares now-1,666,301
- AllianceBernstein LPexisting position · 1,557,810 shares now-395,420
- Neuberger Berman Group LLCexisting position · 199,168 shares now-202,461
- Man Group PLCexisting position · 228,128 shares now-137,746
- D. E. Shaw & Co.existing position · 306,680 shares now-107,056
New positions and exits
New (1)
Exited (1)
- Winton Group Ltdwas $4.6m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 21 | $17.1bn | n.a. | n.a. |
| Q3 2013 | 19 | $19.1bn | n.a. | n.a. |
| Q4 2013 | 22 | $19.9bn | n.a. | n.a. |
| Q1 2014 | 17 | $22.0bn | n.a. | n.a. |
| Q2 2014 | 24 | $20.5bn | n.a. | n.a. |
| Q3 2014 | 27 | $24.1bn | n.a. | n.a. |
| Q4 2014 | 24 | $28.1bn | n.a. | n.a. |
| Q1 2015 | 26 | $28.3bn | n.a. | n.a. |
| Q2 2015 | 28 | $26.3bn | n.a. | n.a. |
| Q3 2015 | 32 | $23.9bn | n.a. | n.a. |
| Q4 2015 | 31 | $27.5bn | n.a. | n.a. |
| Q1 2016 | 29 | $24.2bn | n.a. | n.a. |
| Q2 2016 | 28 | $23.0bn | n.a. | n.a. |
| Q3 2016 | 31 | $24.6bn | n.a. | n.a. |
| Q4 2016 | 25 | $20.3bn | n.a. | n.a. |
| Q1 2017 | 31 | $23.4bn | n.a. | n.a. |
| Q2 2017 | 25 | $25.2bn | n.a. | n.a. |
| Q3 2017 | 25 | $27.3bn | n.a. | n.a. |
| Q4 2017 | 26 | $24.5bn | n.a. | n.a. |
| Q1 2018 | 24 | $20.4bn | n.a. | n.a. |
| Q2 2018 | 20 | $26.9bn | n.a. | n.a. |
| Q3 2018 | 19 | $21.2bn | n.a. | n.a. |
| Q4 2018 | 20 | $18.9bn | n.a. | n.a. |
| Q1 2019 | 28 | $17.0bn | n.a. | n.a. |
| Q2 2019 | 22 | $14.5bn | n.a. | n.a. |
| Q3 2019 | 26 | $16.4bn | n.a. | n.a. |
| Q4 2019 | 21 | $18.7bn | n.a. | n.a. |
| Q1 2020 | 21 | $14.2bn | n.a. | n.a. |
| Q2 2020 | 20 | $16.2bn | n.a. | n.a. |
| Q3 2020 | 16 | $16.3bn | n.a. | n.a. |
| Q4 2020 | 19 | $14.0bn | n.a. | n.a. |
| Q1 2021 | 16 | $14.5bn | n.a. | n.a. |
| Q2 2021 | 23 | $13.8bn | n.a. | n.a. |
| Q3 2021 | 24 | $11.6bn | n.a. | n.a. |
| Q4 2021 | 21 | $10.4bn | n.a. | n.a. |
| Q1 2022 | 23 | $9.9bn | n.a. | n.a. |
| Q2 2022 | 28 | $9.7bn | n.a. | n.a. |
| Q3 2022 | 21 | $7.9bn | n.a. | n.a. |
| Q4 2022 | 24 | $9.3bn | n.a. | n.a. |
| Q1 2023 | 22 | $8.4bn | n.a. | n.a. |
| Q2 2023 | 26 | $7.4bn | n.a. | n.a. |
| Q3 2023 | 26 | $8.7bn | n.a. | n.a. |
| Q4 2023 | 24 | $8.4bn | 14 | 11 |
| Q1 2024 | 25 | $6.7bn | 10 | 15 |
| Q2 2024 | 20 | $8.0bn | 11 | 9 |
| Q3 2024 | 21 | $8.8bn | 16 | 5 |
| Q4 2024 | 20 | $8.2bn | 13 | 7 |
| Q1 2025 | 25 | $12.0bn | 10 | 16 |
| Q2 2025 | 20 | $10.2bn | 13 | 8 |
| Q3 2025 | 17 | $10.4bn | 8 | 9 |
| Q4 2025 | 19 | $18.0bn | 13 | 22 |
| Q1 2026 | 15 | $21.4bn | 17 | 15 |
| Q2 2026 | 23 | $24.9bn | 19 | 13 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
AMGN and GILD →AMGN and ARGX →AMGN and RVMD →Choose a stock to compare with AMGN →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own AMGN, latest filings →Back to the 13F Explorer →